Gerd was reported in 5% of Wegovy users compared to 3% in the placebo arm. It’s a risk but it’s not a huge risk.
Nausea especially in the first few weeks was more common, but it was only bad enough to cause <2% of people to discontinue the trial.
Gerd was reported in 5% of Wegovy users compared to 3% in the placebo arm. It’s a risk but it’s not a huge risk.
Nausea especially in the first few weeks was more common, but it was only bad enough to cause <2% of people to discontinue the trial.